Tanaka M, Takahashi S, Kondo T, Matsumiya N
Department of Anesthesia/Critical Care Medicine, Tsuchiura Kyodo General Hospital, Japan.
Anesth Analg. 1995 Nov;81(5):987-92. doi: 10.1097/00000539-199511000-00016.
A recent study demonstrated that an epidural test dose containing 15 micrograms epinephrine was an imperfect marker for intravascular injection during isoflurane anesthesia based on the conventional heart rate (HR) criterion (positive if > or = 20 bpm increase). We have determined the effects of epinephrine doses and isoflurane concentrations on these efficacies in healthy adult patients during isoflurane anesthesia. Eighty patients were randomly assigned to one of four groups according to the simulated test dose injected intravenously (IV) under 1% end-tidal isoflurane and nitrous oxide after endotracheal intubation. The saline group (n = 20) received 3 mL normal saline; the epinephrine 7.5 group (n = 20) received 3 mL 1.5% lidocaine containing 7.5 micrograms epinephrine; the epinephrine 15 and epinephrine 22.5 groups (n = 20 each) received an identical dose and volume of lidocaine but containing 15 and 22.5 micrograms epinephrine, respectively. HR and systolic blood pressure (SBP) were monitored invasively for 4 min after IV injection of the study drug. Although none in the saline group developed a HR increase > or = 20 bpm, 2, 14, and 12 patients elicited positive responses in the epinephrine 7.5, 15, and 22.5 groups (10%, 70%, and 60% sensitivities), respectively. If a positive HR response was defined by an increase of 10 bpm, sensitivities were 55%, 100%, and 100% in the epinephrine 7.5, 15, and 22.5 groups, respectively. On the other hand, none in the saline group, 12 in the epinephrine 7.5 group, and all patients in the epinephrine 15 and 22.5 groups developed maximum SBP increases > or = 15 mm Hg.(ABSTRACT TRUNCATED AT 250 WORDS)
最近一项研究表明,根据传统心率(HR)标准(心率增加≥20次/分钟为阳性),含15微克肾上腺素的硬膜外试验剂量在异氟烷麻醉期间并非血管内注射的完美标志物。我们已确定在健康成年患者异氟烷麻醉期间,肾上腺素剂量和异氟烷浓度对这些效应的影响。80例患者在气管插管后,根据在1%呼气末异氟烷和氧化亚氮下静脉注射(IV)模拟试验剂量,随机分为四组之一。生理盐水组(n = 20)接受3毫升生理盐水;肾上腺素7.5组(n = 20)接受3毫升含7.5微克肾上腺素的1.5%利多卡因;肾上腺素15组和肾上腺素22.5组(每组n = 20)接受相同剂量和体积的利多卡因,但分别含15和22.5微克肾上腺素。静脉注射研究药物后,有创监测HR和收缩压(SBP)4分钟。虽然生理盐水组无一人心率增加≥20次/分钟,但肾上腺素7.5组、15组和22.5组分别有2例、14例和12例患者出现阳性反应(敏感性分别为10%、70%和60%)。如果将阳性HR反应定义为增加10次/分钟,则肾上腺素7.5组、15组和22.5组的敏感性分别为55%、100%和100%。另一方面,生理盐水组无人、肾上腺素7.5组有12人以及肾上腺素15组和22.5组所有患者的SBP最大增幅≥15毫米汞柱。(摘要截断于250字)